Evidence map›Paper›PMID 34114542›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2021

Mortality review as a tool to assess the contribution of healthcare-associated infections to death: results of a multicentre validity and reproducibility study, 11 European Union countries, 2017 to 2018.

Tjallie van der Kooi, Alain Lepape, Pascal Astagneau, Carl Suetens, Mioara Alina Nicolaie, Sabine de Greeff, Ilma Lozoraitiene, Jacek Czepiel, Márta Patyi, Diamantis Plachouras and 2 more

Open access · diamondAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Attributable mortality to healthcare-associated infections: a comprehensive nationwide assessment in Spain, 2022 and 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 7 countries.

Tjallie van der KooiNational Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Alain LepapeThese authors contributed equally to this work.
Pascal AstagneauThese authors contributed equally to this work.
Carl SuetensEuropean Centre for Disease Prevention and Control, Solna, Sweden.
Mioara Alina NicolaieNational Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Sabine de GreeffNational Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Ilma LozoraitieneVilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania.
Jacek CzepielDepartment of Infectious and Tropical Diseases, Jagiellonian University Medical College, Kraków, Poland.
Márta PatyiBács-Kiskun County Teaching Hospital, Kecskemét, Hungary.
Diamantis PlachourasEuropean Centre for Disease Prevention and Control, Solna, Sweden.
HAI-Net Mortality review study groupThe members of the study group are listed under Investigators.
Members of the HAI-Net Mortality review study group
National Institute for Public Health and the Environment · NLEuropean Centre for Disease Prevention and Control · SEAssistance Publique – Hôpitaux de Paris · FRBács-Kiskun Megyei Kórház · HUHospices Civils de Lyon · FRJagiellonian University · PLOrano (United States) · USVilnius University Hospital Santariskiu Klinikos · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IntroductionThe contribution of healthcare-associated infections (HAI) to mortality can be estimated using statistical methods, but mortality review (MR) is better suited for routine use in clinical settings. The European Centre for Disease Prevention and Control recently introduced MR into its HAI surveillance.AimWe evaluate validity and reproducibility of three MR measures.MethodsThe on-site investigator, usually an infection prevention and control doctor, and the clinician in charge of the patient independently reviewed records of deceased patients with bloodstream infection (BSI), pneumonia,

Indexed as

Clostridium InfectionsCross InfectionDelivery of Health CareEuropean UnionHumansReproducibility of Resultsbloodstream infectionClostridioides difficilehealthcare-associated infectioninter-rater reliabilitymortalitypneumonia

Identifiers

PMID34114542
PMCPMC8193992
OpenAlexW3168972997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.